MediWound (MDWD) EBITDA (2013 - 2026)
MediWound (MDWD) posted quarterly EBITDA of -$6.5 million for Q4 2025, down 32.92% year-over-year from -$9.6 million in Q4 2024, and down 20.46% quarter-over-quarter from -$5.4 million in Q3 2025.
MediWound (MDWD) EBITDA (2013 - 2026) Analysis & Trends
MediWound's EBITDA history runs 13 years deep, the most recent figure standing at -$6.5 million for Q4 2025.
- In Q4 2025, EBITDA fell 32.92% year-over-year to -$6.5 million; the TTM figure through Dec 2025 stood at -$21.6 million (down 35.85% YoY), while the FY2025 annual figure was -$20.3 million, down 37.6% from the prior year.
- EBITDA for Q4 2025 stood at -$6.5 million, down from -$5.4 million in the prior quarter.
- The five-year high for EBITDA was $3.4 million in Q4 2022, with the low at -$6.5 million in Q4 2025.
- The 5-year median for EBITDA is -$3.3 million (2023), against an average of -$3.3 million.
- The sharpest annual moves came in 2022 and 2023: EBITDA surged 219.93% in 2022, then tumbled 194.54% in 2023.
- MediWound's EBITDA stood at -$2.9 million in 2021, then soared by 219.93% to $3.4 million in 2022, then sank by 194.54% to -$3.2 million in 2023, then tumbled by 50.26% to -$4.9 million in 2024, then plunged by 32.92% to -$6.5 million in 2025.
- Business Quant data shows MDWD's EBITDA at -$6.5 million in Q4 2025, -$5.4 million in Q3 2025, and -$5.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 65.27 Bn | 60.09 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 59.18 Bn | 54.04 Bn | 52.00 Mn | -815.00 Mn |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn | 325.05 Mn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 231.44 Mn |
| 7 | BioNTech SE | 28.14 Bn | 9.75 Bn | 668.28 Mn | -375.75 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | -1.55 Mn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | 133.12 Mn |
| 10 | MediWound | 168.78 Mn | 137.78 Mn | 337,000.00 | -9.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.46 Mn |
| Dec 31, 2025 | -6.47 Mn |
| Sep 30, 2025 | -5.37 Mn |
| Jun 30, 2025 | -5.72 Mn |
| Mar 31, 2025 | -4.02 Mn |
| Dec 31, 2024 | -4.86 Mn |
| Sep 30, 2024 | -3.67 Mn |
| Jun 30, 2024 | -4.48 Mn |
| Mar 31, 2024 | -2.85 Mn |
| Dec 31, 2023 | -3.24 Mn |
| Sep 30, 2023 | -2.60 Mn |
| Jun 30, 2023 | -4.01 Mn |
| Mar 31, 2023 | -3.44 Mn |
| Dec 31, 2022 | 3.42 Mn |
| Sep 30, 2022 | -2.47 Mn |
| Jun 30, 2022 | -3.67 Mn |
| Mar 31, 2022 | -2.62 Mn |
| Dec 31, 2021 | -2.86 Mn |
| Sep 30, 2021 | -2.88 Mn |
| Jun 30, 2021 | -2.90 Mn |